Producer

Rugao Qingfeng Casing Co., Ltd.

HQ CN · Rugao, Jiangsu Provincewebsite ↗

One of China's major commercial-scale natural casing processors; located in Rugao, Jiangsu province. Rugao is historically one of China's leading natural casing processing centers — a concentration of casing businesses that has grown up around the hog slaughter industry in Jiangsu. Representative of the Chinese processing cluster that handles ~70% of global natural casing volume. Chinese processors import raw casings (pre-cleaned gut) from source countries, process and salt them, and export finished casings globally. COVID lockdowns 2020-2022 disrupted Rugao and similar Chinese casing processing hubs.

2

Inputs supplied

1

Goods downstream

2

Facilities

0

Stories

What they make

2 inputs Rugao Qingfeng Casing Co., Ltd. supplies

Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.

Where it shows up

Goods downstream

Essential goods that depend on something Rugao Qingfeng Casing Co., Ltd. makes — pick one to see the full supply chain.

What else they do

Business segments

The company's full revenue map — where this supply-chain role fits within their broader business.

  • Salted Natural Hog Casings

    85%
  • Pharmaceutical Mucosa Processing (Cluster-Level)

  • Natural Casing Export & Distribution

Intelligence

What's known

Sourced claims about this company's role in supply chains — chokepoints, concentration, incidents, dual-use connections.

  • Did you know2018

    The same Jiangsu Province cluster of casing processors that supplies approximately 70% of globally traded natural sausage casings also produces a substantial share of the world's crude heparin — because both products come from the same pig intestine. Chinese processors extract the mucosal lining (for heparin) while processing the outer casing wall (for sausage use), making the Chinese casing processing cluster simultaneously the dominant supplier of a food ingredient AND a critical pharmaceutical anticoagulant feedstock. Approximately 80% of the world's crude heparin comes from Chinese pig intestines. The same supply chain disruption (African Swine Fever, COVID lockdowns, trade restrictions) that would cut global casing supply would simultaneously constrain heparin supply for hospitals performing dialysis and cardiac surgery.

    PubMed Central / Academic Research
  • Capacity2019

    African Swine Fever (ASF) devastated China's pig herd in 2018-2020, killing an estimated 40-50% of Chinese pigs — the largest livestock disease event in recorded history. This simultaneously disrupted both the global natural casing supply chain (less Chinese pork → fewer intestines for casing processing) AND the global heparin pharmaceutical supply chain (fewer Chinese pigs → less intestinal mucosa for crude heparin). Chinese hog herd recovery continued through 2021-2023 but the episode demonstrated that a single animal disease event in China creates correlated supply shocks across food processing and pharmaceutical industries that most supply chain risk models treat as completely unrelated sectors.

    Food and Agriculture Organization of the United Nations
  • Origin2021

    Rugao, Jiangsu Province is China's premier natural casing processing center — a city-scale industrial cluster where dozens of casing companies (including Rugao Qingfeng) have concentrated for decades around Jiangsu's hog slaughter industry. During the COVID-19 pandemic (2020-2022), lockdowns and worker quarantine protocols in Rugao and nearby processing cities severely disrupted global natural casing supply, causing shortages and price spikes that affected sausage manufacturers worldwide. The geographic concentration of 70%+ of global natural casing processing capacity in a single Chinese province represents a systemic single-point-of-failure risk for the global processed meat industry.

    Industry sources (Rugao casing cluster)